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Background
Since early Neolithic, Europe as a whole and Balkans in
particular were at the crossroads of human migrations
thereby transmitting human pathogens across the conti-
nent. Bulgaria located near the Europe-Asia border was
in the front of these migrations that left their imprint
on the population structure of human pathogens circu-
lating therein. A re-emergence and wide dissemination
of multidrug-resistant tuberculosis (MDR-TB) threatens
national control problems. The early detection of resis-
tance to first line anti-TB drugs is essential for the effi-
cient treatment and constitutes one of the priorities of
TB control of MDR strains. The rate of the MDR-TB
among newly diagnosed TB patients in Bulgaria was
estimated to be 10.7% that is much higher than in the
neighboring countries. Here we evaluated fast molecular
methods to detect drug resistant TB and studied the dis-
tribution of resistant properties in different clonal
lineages of M. tuberculosis in Bulgaria versus its
neighbors.
Methods
Drug-resistant and susceptible M. tuberculosis strains from
newly–diagnosed patients were studied by different typing
methods (spoligo-, IS6110-RFLP and 24-loci MIRU-VNTR
typing). Mutations in the major gene targets related to
drug resistance (rpoB RRDR, katG315, inhA -15,
embB306) were detected by PCR and microarrays.
Results
The population of M. tuberculosis in Bulgaria was found
sufficiently heterogenous (24-VNTR based HGI=0.89).
Mutation in rpoB531 was detected in the remarkably
high rate among RIF-resistant strains (65%). Mutations
in katG315 and inhA -15 were detected only in 50% of
INH-resistant strains. The embB306 mutation was found
in 63% of EMB-resistant strains. Comparison with geno-
typing results did not identify any strain cluster linked
to drug resistance.
Conclusion
M. tuberculosis population in Bulgaria features several glo-
bal, Balkan- and Bulgaria- specific lineages. rpoB RRDR
and embB306 mutations may serve for rapid genotypic
detection of the majority of RIF and EMB-resistant
M. tuberculosis strains in Bulgaria. The results for INH
resistance are complex and more genes should be studied.
The very high rate of rpoB S531L mutation may correlate
with some specific features of the national TB control pro-
gram (quality of the drug used) or is hypothetically linked
to another molecular mechanism of RIF resistance. A local
circulation of the particular clones appears to be an
important factor to take into consideration in the molecu-
lar epidemiological studies of tuberculosis in Bulgaria.
Emergence and spread of drug-resistant and MDR-TB in
Bulgaria are not associated with any particular spoligotype
or MIRU-VNTR genotype.
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